Skip to main content
Erschienen in: Intensive Care Medicine 1/2008

01.01.2008 | Experimental

Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility

verfasst von: Steffen Rex, Carlo Missant, Patrick Segers, Rolf Rossaint, Patrick F. Wouters

Erschienen in: Intensive Care Medicine | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

Prostacyclins have been suggested to exert positive inotropic effects which would render them particularly suitable for the treatment of right ventricular (RV) dysfunction due to acute pulmonary hypertension (PHT). Data on this subject are controversial, however, and vary with the experimental conditions. We studied the inotropic effects of epoprostenol at clinically recommended doses in an experimental model of acute PHT.

Design and setting

Prospective laboratory investigation in a university hospital laboratory.

Subjects

Six pigs (36 ± 7 kg).

Interventions

Pigs were instrumented with biventricular conductance catheters, a pulmonary artery (PA) flow probe, and a high-fidelity pulmonary pressure catheter. Incremental doses of epoprostenol (10, 15, 20, 30, 40 ng kg–1 min–1) were administered in undiseased animals and after induction of acute hypoxia-induced PHT.

Measurements and results

In acute PHT epoprostenol markedly reduced RV afterload (slopes of pressure-flow relationship in the PA from 7.0 ± 0.6 to 4.2 ± 0.7 mmHg min l–1). This was associated with a paradoxical and dose-dependent decrease in RV contractility (slope of preload-recruitable stroke-work relationship from 3.0 ± 0.4 to 1.6 ± 0.2 mW s ml–1; slope of endsystolic pressure-volume relationship from 1.5 ± 0.3 to 0.7 ± 0.3 mmHg ml–1). Left ventricular contractility was reduced only at the highest dose. In undiseased animals epoprostenol did not affect vascular tone and produced a mild biventricular decrease in contractility.

Conclusions

Epoprostenol has no positive inotropic effects in vivo. In contrast, epoprostenol-induced pulmonary vasodilation in animals with acute PHT was associated with a paradoxical decrease in RV contractility. This effect is probably caused indirectly by the close coupling of RV contractility to RV afterload. However, data from normal animals suggest that mechanisms unrelated to vasodilation are also involved in the observed negative inotropic response to epoprostenol.
Literatur
1.
Zurück zum Zitat Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, Dhainaut JF, Brunet F (1998) Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 158:1076–1081PubMed Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, Dhainaut JF, Brunet F (1998) Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 158:1076–1081PubMed
2.
Zurück zum Zitat Davila-Roman VG, Waggoner AD, Hopkins WE, Barzilai B (1995) Right ventricular dysfunction in low output syndrome after cardiac operations: assessment by transesophageal echocardiography. Ann Thorac Surg 60:1081–1086PubMedCrossRef Davila-Roman VG, Waggoner AD, Hopkins WE, Barzilai B (1995) Right ventricular dysfunction in low output syndrome after cardiac operations: assessment by transesophageal echocardiography. Ann Thorac Surg 60:1081–1086PubMedCrossRef
3.
Zurück zum Zitat D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343–349PubMed D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343–349PubMed
4.
Zurück zum Zitat Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL (2000) Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol 36:255–261PubMedCrossRef Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL (2000) Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol 36:255–261PubMedCrossRef
5.
Zurück zum Zitat Hinderliter AL, Willis PW, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, Jobsis MM, Blackburn SD Jr, Crow JW, Long WA (1997) Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation 95:1479–1486PubMed Hinderliter AL, Willis PW, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, Jobsis MM, Blackburn SD Jr, Crow JW, Long WA (1997) Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation 95:1479–1486PubMed
6.
Zurück zum Zitat McLaughlin VV, Genthner DE, Panella MM, Rich S (1998) Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 338:273–277PubMedCrossRef McLaughlin VV, Genthner DE, Panella MM, Rich S (1998) Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 338:273–277PubMedCrossRef
7.
8.
Zurück zum Zitat Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334:296–302PubMedCrossRef Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334:296–302PubMedCrossRef
9.
Zurück zum Zitat Olschewski H, Rose F, Schermuly R, Ghofrani HA, Enke B, Olschewski A, Seeger W (2004) Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther 102:139–153PubMedCrossRef Olschewski H, Rose F, Schermuly R, Ghofrani HA, Enke B, Olschewski A, Seeger W (2004) Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther 102:139–153PubMedCrossRef
10.
Zurück zum Zitat Kisch-Wedel H, Kemming G, Meisner F, Flondor M, Kuebler WM, Bruhn S, Koehler C, Zwissler B (2003) The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo. Intensive Care Med 29:1574–1583PubMedCrossRef Kisch-Wedel H, Kemming G, Meisner F, Flondor M, Kuebler WM, Bruhn S, Koehler C, Zwissler B (2003) The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo. Intensive Care Med 29:1574–1583PubMedCrossRef
11.
Zurück zum Zitat Montalescot G, Drobinski G, Meurin P, Maclouf J, Sotirov I, Philippe F, Choussat R, Morin E, Thomas D (1998) Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol 82:749–755PubMedCrossRef Montalescot G, Drobinski G, Meurin P, Maclouf J, Sotirov I, Philippe F, Choussat R, Morin E, Thomas D (1998) Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol 82:749–755PubMedCrossRef
12.
Zurück zum Zitat Fassina G, Tessari F, Dorigo P (1983) Positive inotropic effect of a stable analogue of PGI2 and of PGI2 on isolated guinea pig atria. Mechanism of action. Pharmacol Res Commun 15:735–749PubMedCrossRef Fassina G, Tessari F, Dorigo P (1983) Positive inotropic effect of a stable analogue of PGI2 and of PGI2 on isolated guinea pig atria. Mechanism of action. Pharmacol Res Commun 15:735–749PubMedCrossRef
13.
Zurück zum Zitat Pavlovic M, Petkovic D, Cvetkovic M, Macut DJ, Zdjelar K, Nesic M, Bosnic O, Radulovic R, Mihajlovic M (1995) The influence of prostacyclin (PGI2) on contractile properties of isolated right ventricle of rat heart. Experientia 51:941–944PubMedCrossRef Pavlovic M, Petkovic D, Cvetkovic M, Macut DJ, Zdjelar K, Nesic M, Bosnic O, Radulovic R, Mihajlovic M (1995) The influence of prostacyclin (PGI2) on contractile properties of isolated right ventricle of rat heart. Experientia 51:941–944PubMedCrossRef
14.
Zurück zum Zitat Rimoldi O, Pierini S, Pagani MR, Pagani M (1991) Reduced cardiovascular sympathetic excitatory responses during iloprost infusion in conscious dogs. Cardiovasc Res 25:793–801PubMed Rimoldi O, Pierini S, Pagani MR, Pagani M (1991) Reduced cardiovascular sympathetic excitatory responses during iloprost infusion in conscious dogs. Cardiovasc Res 25:793–801PubMed
15.
Zurück zum Zitat Malik KU, Sehic E (1990) Prostaglandins and the release of the adrenergic transmitter. Ann N Y Acad Sci 604:222–236PubMedCrossRef Malik KU, Sehic E (1990) Prostaglandins and the release of the adrenergic transmitter. Ann N Y Acad Sci 604:222–236PubMedCrossRef
16.
Zurück zum Zitat Panzenbeck MJ, Tan W, Hajdu MA, Zucker IH (1988) Intracoronary infusion of prostaglandin I2 attenuates arterial baroreflex control of heart rate in conscious dogs. Circ Res 63:860–868PubMed Panzenbeck MJ, Tan W, Hajdu MA, Zucker IH (1988) Intracoronary infusion of prostaglandin I2 attenuates arterial baroreflex control of heart rate in conscious dogs. Circ Res 63:860–868PubMed
17.
Zurück zum Zitat Lanier SM, Malik KU (1985) Inhibition by prostaglandins of adrenergic transmission in the left ventricular myocardium of anesthetized dogs. J Cardiovasc Pharmacol 7:653–659PubMedCrossRef Lanier SM, Malik KU (1985) Inhibition by prostaglandins of adrenergic transmission in the left ventricular myocardium of anesthetized dogs. J Cardiovasc Pharmacol 7:653–659PubMedCrossRef
18.
Zurück zum Zitat Kisch-Wedel H, Kemming G, Meisner F, Flondor M, Bruhn S, Koehler C, Messmer K, Zwissler B (2005) Effect of prostaglandin I2 analogues on left ventricular diastolic function in vivo. Eur J Pharmacol 517:208–216PubMedCrossRef Kisch-Wedel H, Kemming G, Meisner F, Flondor M, Bruhn S, Koehler C, Messmer K, Zwissler B (2005) Effect of prostaglandin I2 analogues on left ventricular diastolic function in vivo. Eur J Pharmacol 517:208–216PubMedCrossRef
19.
Zurück zum Zitat Baan J, van der Velde ET, de Bruin HG, Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B (1984) Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70:812–823PubMed Baan J, van der Velde ET, de Bruin HG, Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B (1984) Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70:812–823PubMed
20.
Zurück zum Zitat Steendijk P, Staal E, Jukema JW, Baan J (2001) Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 281:H755–H763PubMed Steendijk P, Staal E, Jukema JW, Baan J (2001) Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 281:H755–H763PubMed
21.
Zurück zum Zitat Dickstein ML, Yano O, Spotnitz HM, Burkhoff D (1995) Assessment of right ventricular contractile state with the conductance catheter technique in the pig. Cardiovasc Res 29:820–826PubMedCrossRef Dickstein ML, Yano O, Spotnitz HM, Burkhoff D (1995) Assessment of right ventricular contractile state with the conductance catheter technique in the pig. Cardiovasc Res 29:820–826PubMedCrossRef
22.
Zurück zum Zitat Karunanithi MK, Michniewicz J, Copeland SE, Feneley MP (1992) Right ventricular preload recruitable stroke work, end-systolic pressure-volume, and dP/dtmax-end-diastolic volume relations compared as indexes of right ventricular contractile performance in conscious dogs. Circ Res 70:1169–1179PubMed Karunanithi MK, Michniewicz J, Copeland SE, Feneley MP (1992) Right ventricular preload recruitable stroke work, end-systolic pressure-volume, and dP/dtmax-end-diastolic volume relations compared as indexes of right ventricular contractile performance in conscious dogs. Circ Res 70:1169–1179PubMed
23.
Zurück zum Zitat Burkhoff D, Mirsky I, Suga H (2005) Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 289:H501–H512PubMedCrossRef Burkhoff D, Mirsky I, Suga H (2005) Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 289:H501–H512PubMedCrossRef
24.
Zurück zum Zitat Vroomen M de, Steendijk P, Lopes Cardozo RH, Brouwers HH, van Bel F, Baan J (2001) Enhanced systolic function of the right ventricle during respiratory distress syndrome in newborn lambs. Am J Physiol Heart Circ Physiol 280:H392–H400 Vroomen M de, Steendijk P, Lopes Cardozo RH, Brouwers HH, van Bel F, Baan J (2001) Enhanced systolic function of the right ventricle during respiratory distress syndrome in newborn lambs. Am J Physiol Heart Circ Physiol 280:H392–H400
25.
Zurück zum Zitat Hettrick DA, Warltier DC (1995) Ventriculoarterial Coupling. 1:153–180 Hettrick DA, Warltier DC (1995) Ventriculoarterial Coupling. 1:153–180
26.
Zurück zum Zitat Brimioulle S, Maggiorini M, Stephanazzi J, Vermeulen F, Lejeune P, Naeije R (1999) Effects of low flow on pulmonary vascular flow-pressure curves and pulmonary vascular impedance. Cardiovasc Res 42:183–192PubMedCrossRef Brimioulle S, Maggiorini M, Stephanazzi J, Vermeulen F, Lejeune P, Naeije R (1999) Effects of low flow on pulmonary vascular flow-pressure curves and pulmonary vascular impedance. Cardiovasc Res 42:183–192PubMedCrossRef
27.
Zurück zum Zitat Rex S, Missant C, Segers P, Wouters PF (2007) Thoracic epidural anesthesia impairs the hemodynamic response to acute pulmonary hypertension by deteriorating right ventricular-pulmonary arterial coupling. Crit Care Med 35:222–229PubMedCrossRef Rex S, Missant C, Segers P, Wouters PF (2007) Thoracic epidural anesthesia impairs the hemodynamic response to acute pulmonary hypertension by deteriorating right ventricular-pulmonary arterial coupling. Crit Care Med 35:222–229PubMedCrossRef
28.
Zurück zum Zitat Leeuwenburgh BP, Steendijk P, Helbing WA, Baan J (2002) Indexes of diastolic RV function: load dependence and changes after chronic RV pressure overload in lambs. Am J Physiol Heart Circ Physiol 282:H1350–H1358PubMed Leeuwenburgh BP, Steendijk P, Helbing WA, Baan J (2002) Indexes of diastolic RV function: load dependence and changes after chronic RV pressure overload in lambs. Am J Physiol Heart Circ Physiol 282:H1350–H1358PubMed
29.
Zurück zum Zitat Huez S, Retailleau K, Unger P, Pavelescu A, Vachiery JL, Derumeaux G, Naeije R (2005) Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. Am J Physiol Heart Circ Physiol 289:H1391–H1398PubMedCrossRef Huez S, Retailleau K, Unger P, Pavelescu A, Vachiery JL, Derumeaux G, Naeije R (2005) Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. Am J Physiol Heart Circ Physiol 289:H1391–H1398PubMedCrossRef
30.
Zurück zum Zitat Ludbrook J (1994) Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28:303–311PubMedCrossRef Ludbrook J (1994) Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28:303–311PubMedCrossRef
31.
Zurück zum Zitat Ludbrook J (1998) Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25:1032–1037PubMedCrossRef Ludbrook J (1998) Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25:1032–1037PubMedCrossRef
32.
Zurück zum Zitat Wauthy P, Pagnamenta A, Vassalli F, Naeije R, Brimioulle S (2004) Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol 286:H1441–H1447PubMedCrossRef Wauthy P, Pagnamenta A, Vassalli F, Naeije R, Brimioulle S (2004) Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol 286:H1441–H1447PubMedCrossRef
33.
Zurück zum Zitat Gaynor SL, Maniar HS, Bloch JB, Steendijk P, Moon MR (2005) Right atrial and ventricular adaptation to chronic right ventricular pressure overload. Circulation 112:I212–I218PubMed Gaynor SL, Maniar HS, Bloch JB, Steendijk P, Moon MR (2005) Right atrial and ventricular adaptation to chronic right ventricular pressure overload. Circulation 112:I212–I218PubMed
34.
Zurück zum Zitat Sarnoff SJ, Mitchell JH, Gilmore JP, Remensnyder JP (1960) Homeometric autoregulation in the heart. Circ Res 8:1077–1091PubMed Sarnoff SJ, Mitchell JH, Gilmore JP, Remensnyder JP (1960) Homeometric autoregulation in the heart. Circ Res 8:1077–1091PubMed
35.
Zurück zum Zitat Wauthy P, Abdel KS, Mooi WJ, Naeije R, Brimioulle S (2003) Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension. J Thorac Cardiovasc Surg 126:1434–1441PubMedCrossRef Wauthy P, Abdel KS, Mooi WJ, Naeije R, Brimioulle S (2003) Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension. J Thorac Cardiovasc Surg 126:1434–1441PubMedCrossRef
36.
Zurück zum Zitat Segers P, Stergiopulos N, Westerhof N (2002) Relation of effective arterial elastance to arterial system properties. Am J Physiol Heart Circ Physiol 282:H1041–H1046PubMed Segers P, Stergiopulos N, Westerhof N (2002) Relation of effective arterial elastance to arterial system properties. Am J Physiol Heart Circ Physiol 282:H1041–H1046PubMed
37.
Zurück zum Zitat Naeije R (2003) Pulmonary vascular resistance. A meaningless variable? Intensive Care Med 29:526–529PubMed Naeije R (2003) Pulmonary vascular resistance. A meaningless variable? Intensive Care Med 29:526–529PubMed
38.
Zurück zum Zitat Murray PA, Lodato RF, Michael JR (1986) Neural antagonists modulate pulmonary vascular pressure-flow plots in conscious dogs. J Appl Physiol 60:1900–1907PubMedCrossRef Murray PA, Lodato RF, Michael JR (1986) Neural antagonists modulate pulmonary vascular pressure-flow plots in conscious dogs. J Appl Physiol 60:1900–1907PubMedCrossRef
39.
Zurück zum Zitat Auclair MC, Vernimmen C, Lechat P (1988) Influence of prostacyclin and two metabolites on the contractility of cultured rat heart cells. Prostaglandins Leukot Essent Fatty Acids 32:33–38PubMedCrossRef Auclair MC, Vernimmen C, Lechat P (1988) Influence of prostacyclin and two metabolites on the contractility of cultured rat heart cells. Prostaglandins Leukot Essent Fatty Acids 32:33–38PubMedCrossRef
40.
Zurück zum Zitat Lawler OA, Miggin SM, Kinsella BT (2001) Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling. J Biol Chem 276:33596–33607PubMedCrossRef Lawler OA, Miggin SM, Kinsella BT (2001) Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling. J Biol Chem 276:33596–33607PubMedCrossRef
41.
Zurück zum Zitat Nilius SM, Hasse A, Kuger P, Schror K, Meyer-Kirchrath J (2000) Agonist-induced long-term desensitization of the human prostacyclin receptor. FEBS Lett 484:211–216PubMedCrossRef Nilius SM, Hasse A, Kuger P, Schror K, Meyer-Kirchrath J (2000) Agonist-induced long-term desensitization of the human prostacyclin receptor. FEBS Lett 484:211–216PubMedCrossRef
42.
Zurück zum Zitat Panzenbeck MJ, Hintze TH, Kaley G (1988) 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs. J Pharmacol Exp Ther 244:814–819PubMed Panzenbeck MJ, Hintze TH, Kaley G (1988) 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs. J Pharmacol Exp Ther 244:814–819PubMed
43.
Zurück zum Zitat Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243–2278PubMedCrossRef Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243–2278PubMedCrossRef
44.
45.
Zurück zum Zitat Teerlink JR (2005) Overview of randomized clinical trials in acute heart failure syndromes. Am J Cardiol 96:59G–67GPubMedCrossRef Teerlink JR (2005) Overview of randomized clinical trials in acute heart failure syndromes. Am J Cardiol 96:59G–67GPubMedCrossRef
46.
Zurück zum Zitat Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R (2007) How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med 175:846–850PubMedCrossRef Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R (2007) How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med 175:846–850PubMedCrossRef
47.
Zurück zum Zitat Guth BD, Schulz R, Heusch G (1991) Pressure-flow characteristics in the right and left ventricular perfusion territories of the right coronary artery in swine. Pflugers Arch 419:622–628PubMedCrossRef Guth BD, Schulz R, Heusch G (1991) Pressure-flow characteristics in the right and left ventricular perfusion territories of the right coronary artery in swine. Pflugers Arch 419:622–628PubMedCrossRef
Metadaten
Titel
Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility
verfasst von
Steffen Rex
Carlo Missant
Patrick Segers
Rolf Rossaint
Patrick F. Wouters
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 1/2008
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-007-0831-8

Weitere Artikel der Ausgabe 1/2008

Intensive Care Medicine 1/2008 Zur Ausgabe

Announcements

Announcement

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.